Ascend Capital’s Illumina ILMN Stock Holding History

Ascend Capital’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-50,179	Closed	-$6.25M	–	155
2016 Q4	$6.25M	Buy	+50,179	New	+$6.76M	0.31%	86

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ascend Capital's ILMN Position: Q1 2017 in Review

Ascend Capital sold out of Illumina (ILMN) in Q1 2017, closing a stake of 50,179 shares — an estimated $6.25M sold.

Ascend Capital first reported a position in ILMN in Q4 2016 and held it in 1 quarter. The position peaked at $6.25M in Q4 2016. 530 funds tracked by Wall St. Rank hold ILMN as of Q1 2017.

Ascend Capital reported no remaining Illumina position as of Q1 2017 after selling out during the quarter.
Ascend Capital sold 50,179 Illumina shares in Q1 2017, an estimated $6.25M.
Ascend Capital first reported a position in Illumina in Q4 2016 and held it in 1 quarter.
Ascend Capital's Illumina position peaked at $6.25M in Q4 2016.
530 funds tracked by Wall St. Rank held Illumina as of Q1 2017.

Based on Ascend Capital's 13F filing for Q1 2017, filed 15 May 2017.